Protagenic Therapeutics Inc. (PTIX)

[point_east]

some action could be coming mid-2018

from the 04/05/2018 10K
http://m2compliance.com/hosting/company/PTIX/link_files/2018/04-05-2018/Form10-KA_(04-05-2018)_ProtagenicTherapeuticsInc/Form10-KA.pdf

"(2) In the absence of a licensing opportunity with a large pharmaceutical partner, we may undertake an equity financing in mid-2018, in order to raise $5-10 million in working capital to fund our first two phases of clinical trials. In this event, Management would aim to disclose additional pre-clinical research results prior to or coincident with this possible equity financing, because this would represent a developmental milestone that could increase the value of the Company’s equity in the view of future investors."